𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)

✍ Scribed by Anne Pick; Werner Klinkhammer; Michael Wiese

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
423 KB
Volume
5
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: Novel Lead for Pote
ChemInform Abstract: Novel Lead for Potent Inhibitors of Breast Cancer Resistance Protein (BCRP).
✍ Anne Pick; Henrik Mueller; Michael Wiese πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 26 KB πŸ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Expression of drug resistance proteins i
Expression of drug resistance proteins in breast cancer, in relation to chemotherapy
✍ Sabine C. Linn; Herbert M. Pinedo; Jannette van Ark-Otte; Paul van der Valk; Kla πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 228 KB πŸ‘ 2 views

Drug resistance plays an important role in chemotherapy failure in breast cancer. We studied the expression of MDR1, MRP, LRP, DNA topoisomerases, p53 and Ki-67 in different groups of breast cancer patients in relation to chemotherapy. Tissues from 6 normal breasts and 20 primary operable, 40 locall

Methylation status of breast cancer resi
Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells
✍ Hirofumi Nakano; Yoichi Nakamura; Hiroshi Soda; Megumi Kamikatahira; Kanako Uchi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 483 KB

## Abstract ## BACKGROUND Breast cancer resistance protein (BCRP) functions as a drug efflux transporter that mediates drug resistance. Topoisomerase I inhibitors, including 7‐ethyl‐10‐hydroxycamptothecin (SN‐38), are substrates effluxed by BCRP. However, it remains unclear whether the overexpress